There was no difference in the proportion of patients discharged early despite more patients being classified as low risk by the EDACS-ADP than the ADAPT-ADP. Both accelerated diagnostic pathways are effective strategies for chest pain assessment and resulted in an increased rate of early discharges compared with previously reported rates.

No abstract

We propose a theoretical idea to use an ultracold Fermi gas as a quantum simulator for the study of the low-density region of a neutron-star interior. Our idea is different from the standard quantum simulator that heads for perfect replication of another system, such as the Hubbard model discussed in high-T c cuprates. Instead, we use the similarity between two systems and theoretically make up for the difference between them. That is, (1) we first show that the strong-coupling theory developed by Nozières and Schmitt-Rink (NSR) can quantitatively explain the recent experiment on the equation of state (EoS) in a 6 Li superfluid Fermi gas in the BCS (Bardeen-CooperSchrieffer) unitary limit far below the superfluid phase-transition temperature T c . This region is considered to be very similar to the low-density region (crust regime) of a neutron star (where a nearly unitary s-wave neutron superfluid is expected). (2) We then theoretically compensate the difference that, while the effective range r eff is negligibly small in a superfluid 6 Li Fermi gas, it cannot be ignored (r eff = 2.7 fm) in a neutron star, by extending the NSR theory to include effects of r eff . The calculated EoS when r eff = 2.7 fm is shown to agree well with the previous neutron-star EoS in the low-density region predicted in nuclear physics. Our idea indicates that an ultracold atomic gas may more flexibly be used as a quantum simulator for the study of other complicated quantum many-body systems, when we use not only the experimental high tunability, but also the recent theoretical development in this field. Since it is difficult to directly observe a neutron-star interior, our idea would provide a useful approach to the exploration for this mysterious astronomical object.

We theoretically present an economical and convenient way to study ground-state properties of a strongly interacting superfluid Fermi gas. Our strategy is that complicated strong-coupling calculations are used only to evaluate quantum fluctuation corrections to the chemical potential µ.Then, without any further strong-coupling calculations, we calculate the compressibility, sound velocity, internal energy, pressure, and Tan's contact, from the calculated µ without loss of accuracy, by using exact thermodynamic identities. Using a recent precise measurement of µ in a superfluid 6 Li Fermi gas, we show that an extended T -matrix approximation (ETMA) is suitable for our purpose, especially in the BCS-unitary regime, where our results indicate that many-body corrections are dominated by superfluid fluctuations. Since precise determinations of physical quantities are not always easy in cold Fermi gas physics, our approach would greatly reduce experimental and theoretical efforts toward the understanding of ground-state properties of this strongly interacting Fermi system.

In vivo bioconjugation to the free thiol on Cys34 of serum albumin by a strategically placed reactive group on a bioactive peptide is a useful tool to extend plasma half-life. Three maleimido derivates of human GH-releasing factor (hGRF)(1-29) were synthesized and bioconjugated to human serum albumin ex vivo. All three human serum albumin conjugates showed enhanced in vitro stability against dipeptidylpeptidase-IV and were bioactive in a GH secretion assay in cultured rat anterior pituitary cells. When the maleimido derivatives were individually administered sc to normal male Sprague Dawley rats, an acute secretion of GH was measured in plasma. The best compound, CJC-1295, showed a 4-fold increase in GH area under the curve over a 2-h period compared with hGRF(1-29). CJC-1295, a tetrasubstituted form of hGRF(1-29) with an added N epsilon-3-maleimidopropionamide derivative of lysine at the C terminus, was selected for further pharmacokinetic evaluation, where it was found to be present in plasma beyond 72 h. A Western blot analysis of the plasma of a rat injected with CJC-1295 showed the presence of a CJC-1295 immunoreactive species on the band corresponding to serum albumin, appearing after 15 min and remaining in circulation beyond 24 h. These results led to the identification of CJC-1295 as a stable and active hGRF(1-29) analog with an extended plasma half-life.

A series of human insulin maleimido derivatives with short and long linkers was synthesized by exploiting the variations in the pK(a) values and environment of the three amino groups present in the protein. The syntheses were accomplished in organic solvent because of maleimide's instability in basic aqueous media. The derivatives thus obtained were conjugated to the free thiol on Cys34 of human serum albumin (HSA) and purified. A structure-activity relationship based on in vitro receptor binding and activation results for this series of insulin-HSA conjugates showed that the best compounds were attached at the B1 position of insulin with either short or long linkers. Two conjugates were administered subcutaneously to streptozotocin-induced diabetic rats and found to possess blood glucose normalizing activity up to 8 h post-administration. The return to diabetic plasma glucose levels was not observed within the time frame of the experiment (48 h). In comparison, the insulin-treated group's normalization activity lasted 2 h and returned to a diabetic level at 8 h. The onset of the conjugate activities were delayed by 1 h when compared to the activity of human insulin. The study results led to the identification of CJC-1575 as a potent and long lasting human insulin analogue.

Summary Malaria is endemic in the whole of Zambia and is the leading cause of morbidity and mortality. Prior to 1980, effective malaria control was achieved in the northern mining towns of Chingola and Chililabombwe by means of annual residual spraying programmes. In the 1970s, incidence rates wereaslow as 20/1000 p.a., but by 2000 had increased to 68/1000 p.a. in Chingola and to 158/1000p.a.in Chililabombwe. Konkola Copper Mines (KCM) initiated a malaria control programme in which all dwellings in the two towns and within a 10‐km radius were sprayed with either dichlorodiphenyltrichloroethane or a synthetic pyrethroid (Icon by ZENECA or Deltamethrin by Aventis). Houses were sprayed in November and December 2000, at the start of the peak transmission period. There was a statistically significant reduction in malaria incidence recorded at KCM health facilities in the two towns, representing a protective incidence rate ratio of 0.65 (95% CI 0.44, 0.97) when comparing the post‐spraying period with the corresponding period of the previous 2 years. This reduction followed a single round of house spraying during a year with higher rainfall than the preceding two and in an area where chloroquine was first‐line treatment. This house‐spraying programme is an example of private/public sector collaboration in malaria control.

No abstract